Table 1.
Bivariate analysis of female respondent characteristics: full sample and those with HPV completiona, b. Bold indicates statistically significant p-values that are less than p=0.05.
| Total (N = 9058) | %c (95% CI) | HPV completiond (N = 3246) | %c (95% CI) | p-Valuee | |
|---|---|---|---|---|---|
| Age (mother) | 0.738 | ||||
| ≤ 34 years | 671 | 10.0 (8.8, 11.4) | 217 | 10.4 (8.1, 13.2) | |
| 35–44 years | 3709 | 45.3 (43.5, 47.2) | 1304 | 44.2 (41.1, 47.4) | |
| ≥ 45 years | 4678 | 44.6 (42.8, 46.5) | 1725 | 45.4 (42.3, 48.5) | |
| Education (mother) | 0.007 | ||||
| < 12 years | 905 | 14.3 (12.8, 15.9) | 352 | 16.7 (14.0, 19.7) | |
| 12 years | 1723 | 24.0 (22.4, 25.8) | 615 | 23.7 (21.1, 26.5) | |
| > 12 years (some college) | 2547 | 27.8 (26.1, 29.5) | 836 | 24.1 (21.6, 26.8) | |
| College graduate | 3883 | 33.9 (32.3, 35.6) | 1443 | 35.5 (32.7, 38.5) | |
| Poverty status | 0.048 | ||||
| Above poverty (>$75 k) | 3943 | 33.4 (31.8, 35.1) | 1472 | 34.4 (31.6, 37.3) | |
| Above poverty (≤$75 k) | 3335 | 39.2 (37.3, 41.0) | 1101 | 35.9 (32.9, 39.1) | |
| Below poverty | 1515 | 27.4 (25.6, 29.4) | 587 | 29.7 (26.5, 33.0) | |
| Missing, n (%) | 265 (2.93) | 86 (2.65) | |||
| Marital status (mother) | 0.944 | ||||
| Married | 6691 | 64.0 (62.1, 65.9) | 2354 | 64.1 (60.9, 67.1) | |
| Other | 2367 | 36.0 (34.1, 37.9) | 892 | 35.9 (32.9, 39.1) | |
| Adolescent's race/ethnicity | 0.262 | ||||
| Hispanic | 1231 | 21.8 (20.1, 23.7) | 455 | 23.2 (20.2, 26.5) | |
| Non-Hispanic White only | 6058 | 54.2 (52.4, 56.1) | 2151 | 54.7 (51.5, 57.8) | |
| Non-Hispanic Black only | 899 | 14.2 (12.9, 15.7) | 306 | 12.3 (10.4, 14.6) | |
| Other | 870 | 9.7 (8.6, 11.0) | 334 | 9.8 (8.0, 11.9) | |
| Adolescent's current grade | < 0.001 | ||||
| 6th to 8th grade | 2511 | 27.1 (25.5, 28.7) | 590 | 18.0 (15.8, 20.5) | |
| 9th to 12th grade | 6441 | 71.5 (69.8, 73.1) | 2615 | 80.9 (78.5, 83.2) | |
| HS graduate/GED | 106 | 1.4 (1.0, 2.1) | 41 | 1.0 (0.6, 1.7) | |
| Adolescent's health insurance | 0.475 | ||||
| Employment/union | 5928 | 56.6 (54.7, 58.5) | 2102 | 55.6 (52.4, 58.8) | |
| Other | 3054 | 43.4 (41.5, 45.3) | 1118 | 44.4 (41.2, 47.6) | |
| Missing, n (%) | 76 (0.84) | 26 (0.80) | |||
| Facility type for adolescent's providers | < 0.001 | ||||
| All public facilities | 1270 | 15.5 (14.1, 17.0) | 367 | 12.1 (10.0, 14.5) | |
| All hospital facilities | 793 | 7.4 (6.5, 8.3) | 337 | 8.1 (6.6, 9.8) | |
| All private facilities | 4213 | 50.8 (49.0, 52.7) | 1567 | 55.4 (52.2, 58.6) | |
| Mixed/other | 2427 | 26.3 (24.7, 28.0) | 861 | 24.5 (21.9, 27.3) | |
| Missing, n (%) | 355 (3.92) | 114 (3.51) | |||
| Do adolescent's providers order vaccinations from state/local health department | 0.052 | ||||
| All providers | 5988 | 64.5(62.6, 66.3) | 2232 | 67.3 (64.2, 70.2) | |
| Some but possibly not all | 1309 | 14.0 (12.8, 15.4) | 466 | 13.9 (11.8, 16.4) | |
| No providers | 1008 | 11.7 (10.6, 12.9) | 316 | 11.0 (9.3, 12.9) | |
| Don't know | 728 | 9.8 (8.6, 11.2) | 232 | 7.9 (6.3, 9.7) | |
| Missing, n (%) | 25 (0.28) | ||||
| Influenza vaccinationf | < 0.001 | ||||
| Yes | 3850 | 38.9 (37.2, 40.7) | 1887 | 56.0 (52.8, 59.1) | |
| No | 5208 | 61.1 (59.3, 62.8) | 1359 | 44.0 (40.9, 47.2) | |
| TDAP vaccinationg | < 0.001 | ||||
| Yes | 6085 | 65.0 (63.2, 66.8) | 2465 | 72.4 (69.2, 75.4) | |
| No | 2973 | 35.0 (33.2, 36.9) | 781 | 27.6 (24.7, 30.7) | |
| Meningitis vaccinationh | < 0.001 | ||||
| Yes | 6657 | 73.5 (71.7, 75.1) | 2916 | 90.7 (88.5, 92.4) | |
| No | 2401 | 26.5 (24.9, 28.3) | 330 | 9.3 (7.6, 11.5) |
Respondents from the Virgin Islands were excluded.
Female adolescents in the U.S. with adequately complete provider-reported immunization records in the 2012 NIS-Teen survey were included in the analysis.
Weighted percentages from Dual-Frame Sampling Weights.
HPV completion includes those who had received at least 3 doses of the HPV vaccine.
Survey weighted Pearson chi-square test compared those with HPV vaccine completion to those who did not receive 3 doses.
Adolescent has taken at least one dose of seasonal influenza vaccination in the past three years.
Adolescent has taken at least one dose of TDAP only vaccination since age 10 years old and before 13 years old.
Adolescent has taken at least one dose of Meningitis vaccination.